Control Bionics Ltd
ASX:CBL

Watchlist Manager
Control Bionics Ltd Logo
Control Bionics Ltd
ASX:CBL
Watchlist
Price: 0.06 AUD 9.09% Market Closed
Market Cap: AU$24.7m

Relative Value

CBL doesn't have a meaningful market cap.

The Relative Value of one CBL stock under the Base Case scenario is 0.05 AUD. Compared to the current market price of 0.06 AUD, Control Bionics Ltd is Overvalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CBL Relative Value
Base Case
0.05 AUD
Overvaluation 14%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

CBL Competitors Multiples
Control Bionics Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Control Bionics Ltd
ASX:CBL
24.7m AUD 3.6 -3.8 -3.5 -3.5
US
Abbott Laboratories
NYSE:ABT
183.1B USD 4.1 28.1 16.1 22.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
169.7B USD 16.9 59.4 45.1 55.4
US
Stryker Corp
NYSE:SYK
128.4B USD 5.1 39.6 20.2 24.4
IE
Medtronic PLC
NYSE:MDT
110.6B USD 3.1 24 13.3 19.3
US
Boston Scientific Corp
NYSE:BSX
103B USD 5.1 35.6 20.9 28.1
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD 7.9 44.7 24.6 26.9
DE
Siemens Healthineers AG
XETRA:SHL
41.4B EUR 1.8 19.6 11 15.5
US
IDEXX Laboratories Inc
NASDAQ:IDXX
46B USD 10.7 43.4 30.8 34.1
US
Becton Dickinson and Co
NYSE:BDX
43.9B USD 2 25 9.9 16.7
US
Resmed Inc
NYSE:RMD
32.9B USD 6.1 22.2 15.6 17.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Control Bionics Ltd
ASX:CBL
Average EV/EBITDA: 20.7
Negative Multiple: -3.5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.1
11%
1.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
45.1
23%
2
US
Stryker Corp
NYSE:SYK
20.2
12%
1.7
IE
Medtronic PLC
NYSE:MDT
13.3
8%
1.7
US
Boston Scientific Corp
NYSE:BSX
20.9
18%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
24.6
14%
1.8
DE
Siemens Healthineers AG
XETRA:SHL
11
10%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
30.8
11%
2.8
US
Becton Dickinson and Co
NYSE:BDX
9.9
1%
9.9
US
Resmed Inc
NYSE:RMD
15.6
11%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Control Bionics Ltd
ASX:CBL
Average EV/EBIT: 26
Negative Multiple: -3.5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.1
18%
1.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.4
25%
2.2
US
Stryker Corp
NYSE:SYK
24.4
16%
1.5
IE
Medtronic PLC
NYSE:MDT
19.3
17%
1.1
US
Boston Scientific Corp
NYSE:BSX
28.1
25%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
26.9
15%
1.8
DE
Siemens Healthineers AG
XETRA:SHL
15.5
15%
1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.1
12%
2.8
US
Becton Dickinson and Co
NYSE:BDX
16.7
15%
1.1
US
Resmed Inc
NYSE:RMD
17.3
12%
1.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett